N-1-13C-Hexadecanoyl-D-erythro-sphingosylphosphorylcholine

CATALOG # 2200
Amount 1mg
Price $260.00
Qty
 
N-1-13C-Hexadecanoyl-sphingosylphosphorylcholine
  • Catalog #:2200
  • Scientific Name:N-1-13C-Hexadecanoyl-D-erythro-sphingosylphosphorylcholine
  • Common Name:D-erythro-Spingomyelin with 1-13C-palmitic acid; N-1-13C-Palmitoyl-sphingosylphosphorylcholine
  • Empirical Formula:12C3813CH79N2O6P
  • SDSView Safety Data Sheet
  • Data Sheet:View Data Sheet
  • Formula Weight:703
  • Unit:1mg
  • Solvent:none
  • Source:semisynthetic
  • Purity:98+%
  • Analytical Methods:TLC
  • Natural Source:bovine
  • Solubility:chloroform, methanol, ethanol
  • Physical Appearance:solid
  • Storage:-20°C
  • Dry Ice:No
  • Hazardous:No
  • Literature References:
    1. R. N. Kolesnick, A. Haimovitz-Friedman, Z. Fuks “The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation” Biochem Cell Biol., Vol. 72(11-12) pp. 471-474, 1994
    2. M. Schmuth, et al. “Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis” J Invest Dermatol., Vol. 115(3) pp. 459-466, 2000
    3. C. St Clair et al. “The probability of neonatal respiratory distress syndrome as a function of gestational age and lecithin/sphingomyelin ratio” Am J Perinatol., Vol. 25(8) pp. 473-480, 2008,
    4. J. Kilkus et al. “Differential regulation of sphingomyelin synthesis and catabolism in oligodendrocytes and neurons” J Neurochem. Vol. 106(4) pp. 1745- 1757, 2008
    5. N. Duan RD. “Absorption and lipoprotein transport of sphingomyelin” J Lipid Res., Vol. 47(1) pp. 154-171, 2006
    6. R. Veldman et al. “N-hexanoyl-sphingomyelin potentiates in vitro doxorubicin cytotoxicity by enhancing its cellular influx” Nature, Vol. 90 pp. 917-925, 2004